Cargando…

S4-KL-1 UPDATE OF WHO2016 CLASSIFICATION OF ADULT DIFFUSE GLIOMAS

The World Health Organization (WHO) central nervous system (CNS) tumor classification has represented the primary source of diagnosis and grading criteria of brain tumors. Nonetheless, recent advances of studies on their molecular alterations require more rapid update of recommendations for clinical...

Descripción completa

Detalles Bibliográficos
Autor principal:	Komori, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213220/ http://dx.doi.org/10.1093/noajnl/vdz039.014

Ejemplares similares

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
por: Paul, Yashna, et al.
Publicado: (2017)

Pathology and Genetics of Diffuse Gliomas in Adults
por: KOMORI, Takashi
Publicado: (2015)

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)

Adult type diffuse gliomas in the new 2021 WHO Classification
por: Antonelli, Manila, et al.
Publicado: (2022)

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
por: KOMORI, Takashi
Publicado: (2017)

MPC-17 2021 WHO Classification of Tumors of the CNS, 5th ed
por: Komori, Takashi
Publicado: (2021)

SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
por: Hamamoto, Ryuji
Publicado: (2019)

S5-KL-1 CANCER GENOMIC MEDICINE: FROM BENCH TO CLINIC
por: Aburatani, Hiroyuki
Publicado: (2019)

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update
por: Whitfield, Benjamin T., et al.
Publicado: (2022)

S5-KL-1 CURRENT TREATMENT FOR DLBCL AND PROPHYLAXIS AND TREATMENT FOR SECONDARY CNS LYMPHOMA
por: Izutsu, Koji
Publicado: (2019)

From Theory to Practice: Implementing the WHO 2021 Classification of Adult Diffuse Gliomas in Neuropathology Diagnosis
por: Martin, Karina Chornenka, et al.
Publicado: (2023)

The Rockefeller University Clinical Scholars (KL2) program 2006–2016
por: Schlesinger, Sarah J., et al.
Publicado: (2018)

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
por: Brito, Cheila, et al.
Publicado: (2019)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

AS1-KL-1 DEVELOPMENT OF HIGH-DOSE CHEMOTHERAPY INCLUDING THIOTEPA COMBINED WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL RESCUE
por: Hara, Junichi
Publicado: (2019)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

Keynote Lectures (KL)
Publicado: (2017)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis
por: Roux, Alexandre, et al.
Publicado: (2021)

Classification in the Information Age : Proceedings of the 22nd Annual GfKl Conference
por: Gaul, Wolfgang, et al.
Publicado: (1999)

Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022)

MPC-17 USEFULNESS OF INTRAOPERATIVE MOLECULAR DIAGNOSIS OF GLIOMA USING REAL-TIME PCR
por: Koriyama, Shunichi, et al.
Publicado: (2019)

Draft Genome Sequences of Pseudomonas moraviensis UCD-KL30, Vibrio ostreicida UCD-KL16, Colwellia sp. Strain UCD-KL20, Shewanella sp. Strain UCD-KL12, and Shewanella sp. Strain UCD-KL21, Isolated from Seagrass
por: Lujan, Karley M., et al.
Publicado: (2017)

Aggressive lymphoma 2016: revision of the WHO classification
por: Beham-Schmid, Christine
Publicado: (2017)

Updates on the WHO diagnosis of IDH-mutant glioma
por: Reuss, David.E.
Publicado: (2023)

Imaging-Based Versus Pathologic Survival Stratifications of Diffuse Glioma According to the 2021 WHO Classification System
por: Lee, So Jeong, et al.
Publicado: (2023)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Review of Kl3 theory
por: Callan, C
Publicado: (1969)

Classification. Class KL-KWX, Law of Asia and Eurasia, Africa, Pacific Area, and Antarctica.
Publicado: (1993)

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
por: Ochirjav, Enkhee, et al.
Publicado: (2019)

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults
por: Takeshima, Yuki, et al.
Publicado: (2021)

Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
por: Im, Jung Ho, et al.
Publicado: (2018)

KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome
por: Kida, Yoshiko, et al.
Publicado: (2012)

Measurement of the KL0 → $\pi \mu \nu$ absolute decay rate; further results on KL0 → $\pi$ e $\nu$ , and measurement of the KL0 mean life
por: Lowys, J P, et al.
Publicado: (1967)

NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification
por: Shirota, Masami, et al.
Publicado: (2021)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Impact of the revised WHO classification of diffuse low-grade glioma on clinical decision making: A case report
por: van der Vlis, Tim A. M. Bouwens, et al.
Publicado: (2017)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1b8rbnhugl0htjiiamth1jf2s1